223 related articles for article (PubMed ID: 710804)
1. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
Shimizu F; Arakawa M
Gan; 1978 Aug; 69(4):545-8. PubMed ID: 710804
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
Akaike Y; Arai Y; Taguchi H; Satoh H
Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
5. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
[No Abstract] [Full Text] [Related]
6. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
[No Abstract] [Full Text] [Related]
7. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
Hisamatsu T; Uchida S
Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
9. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
Hoshi A; Iigo M; Nakamura A; Yoshida M; Kuretani K
Gan; 1976 Oct; 67(5):725-31. PubMed ID: 1017587
[TBL] [Abstract][Full Text] [Related]
11. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor activity of various derivatives of nitrosourea].
Ostrovskaia LA; Krugliak SA; Vermel' EM
Vopr Onkol; 1966; 12(10):83-7. PubMed ID: 4301436
[No Abstract] [Full Text] [Related]
13. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
Fujimoto S; Wang Y; Ogawa M
Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
[TBL] [Abstract][Full Text] [Related]
14. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on experimental brain tumors.
Hasegawa H; Shapiro WR; Posner JB; Basler G
Cancer Res; 1979 Jul; 39(7 Pt 1):2687-90. PubMed ID: 445472
[No Abstract] [Full Text] [Related]
16. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
Mihich E; Gelzer J
Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
[No Abstract] [Full Text] [Related]
17. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
Maral R; Bourat G; Ducrot R; Fournel J; Ganter P; Julou L; Koenig F; Myon J; Pascal S; Pasquet J; Populaire P; de Ratuld Y; Werner GH
Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
[No Abstract] [Full Text] [Related]
18. Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors.
Berger M; Zeller WJ; Eisenbrand G; Lin PZ; Nakra M; Schmähl D
Arzneimittelforschung; 1982; 32(5):481-4. PubMed ID: 6285938
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
Shimizu K; Ushio Y; Hayakawa T; Mogami H
Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
[TBL] [Abstract][Full Text] [Related]
20. [A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). II. Experimental antitumor activity].
Maral R; Bourat G; Fournel J; Ganter P; de Ratuld Y; Werner GH
Arzneimittelforschung; 1967 Aug; 17(8):939-48. PubMed ID: 4299568
[No Abstract] [Full Text] [Related]
[Next] [New Search]
